CAS RN: 25700-16-7
4-(1H-imidazol-1-yl)pyridine
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260301
100mg / 250mg / 500mg
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 25700-16-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Beijing
Inquiry
25700-16-7 / 4-imidazol-1-ylpyridine
Standard CAS: 25700-16-7
Multi CAS: No
Basic Information
copy
CAS
25700-16-7 copy
Multi CAS
No copy
Molecular Formula
C8H7N3 copy
Molecular Weight
145.160000 copy
Exact Mass
145.063997 copy
InChI
InChI=1S/C8H7N3/c1-3-9-4-2-8(1)11-6-5-10-7-11/h1-7H copy
InChIKey
JNDMBEDJCZRWLO-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Aromatic heavy atom count
11 copy
Rotatable bonds
1 copy
H-bond acceptors
3 copy
Molar refractivity
41.36 copy
TPSA
30.71 copy
LogP / Solubility
WLOGP
1.27 copy
MLOGP
1.11 copy
XLogP3
0.6 copy
Consensus LogP
0.99 copy
Log S (ESOL)
-2.21 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-1.67 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.78 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.71 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy